Multiple Functional Sp1 Domains in the Minimal Promoter Region of the Neuronal Nicotinic Receptor alpha 5 Subunit Gene*

Antonio Campos-CaroDagger §, Carmen Carrasco-SerranoDagger §parallel , Luis M. ValorDagger §parallel , Salvador ViniegraDagger §, Juan J. Ballesta§**, and Manuel CriadoDagger §Dagger Dagger

From the Departments of Dagger  Neurochemistry and ** Pharmacology and the § Instituto de Neurociencias, Universidad Miguel Hernández, 03550 San Juan, Alicante, Spain

    ABSTRACT
Top
Abstract
Introduction
References

The alpha 5 subunit is a component of the neuronal nicotinic acetylcholine receptors, which are probably involved in the activation step of the catecholamine secretion process in bovine adrenomedullary chromaffin cells. The promoter of the gene coding for this subunit was isolated, and its proximal region was characterized, revealing several GC boxes located close to the site of transcription initiation (from -111 to -40). Deletion analysis and transient transfections showed that a 266-base pair region (-111 to +155) gave rise to ~77 and 100% of the maximal transcriptional activity observed in chromaffin and SHSY-5Y neuroblastoma cells, respectively. Site-directed mutagenesis of five different GC motifs indicated that all of them contribute to the activity of the alpha 5 gene, but in a different way, depending on the type of transfected cell. Thus, in SHSY-5Y cells, alteration of the most promoter-proximal of the GC boxes decreased alpha 5 promoter activity by ~50%, whereas single mutations of the other GC boxes had no effect. In chromaffin cells, by contrast, modification of any of the GC boxes produced a similar decrease in promoter activity (50-69%). In both cell types, however, activity was almost abolished when four GC boxes were suppressed simultaneously. Electrophoretic mobility shift assays using nuclear extracts from either chromaffin or SHSY-5Y cells showed the specific binding of Sp1 protein to fragment -111 to -27. Binding of Sp1 to the GC boxes was also demonstrated by DNase I footprint analysis. This study suggests that the general transcription factor Sp1 plays a dominant role in alpha 5 subunit expression, as has also been demonstrated previously for alpha 3 and beta 4 subunits. Since these three subunits have their genes tightly clustered and are expressed in chromaffin cells, probably as components of the same receptor subtype, we propose that Sp1 constitutes the key factor of a regulatory mechanism common to the three subunits.

    INTRODUCTION
Top
Abstract
Introduction
References

Nicotinic acetylcholine receptors (nAChRs)1 are members of the gene superfamily of neurotransmitter-gated ion channels (1, 2). These multimeric receptors are heteromers or, in some cases, homomers of subunits (alpha 2-alpha 9 and beta 2-beta 4) that exhibit well defined and restricted expression patterns in vivo (1). The diversity of neuronal nAChRs arises, at least in part, from the different combinations of subunits able to form functional nAChRs (3). Thus, it is clear that their differential expression affects the electrophysiological and pharmacological properties of the resultant receptors (4). Moreover, potential changes in subunit expression in response to modulation of synaptic function might have important consequences on the signals transduced by nAChRs (5).

To understand how the regional and developmental expression of nAChR subunits is controlled, we have started to analyze the transcriptional mechanisms that regulate expression of the nAChR subunits expressed in chromaffin cells of the bovine adrenal gland. This cell type represents a relevant and accessible model in which to study a particular neuronal nAChR subtype with a well defined function. Previously, we cloned the bovine alpha 3 (6), alpha 5 and beta 4 (7), and alpha 7 (8) subunits of neuronal nAChRs, which are expressed in chromaffin cells as components of the two nAChR subtypes typically present at the peripheral nervous system (9). We have also shown that nAChRs formed by alpha 7 subunits are differentially expressed in adrenergic cells (10), probably as the result of transcriptional regulation, whereas alpha 3, alpha 5, and beta 4 subunits have a less restricted distribution in adrenergic and noradrenergic cells (7). Interestingly, the alpha 3, alpha 5, and beta 4 subunit genes have been found tightly clustered in the avian (11) and mammalian (12) genomes, with the alpha 3 and alpha 5 genes contiguous and having opposed transcription polarity. A number of studies have concentrated on the transcriptional regulation of the alpha 3 and beta 4 subunits. Deneris and co-workers (13, 14) have shown that the POU domain factor SCIP/Tst-1 is able to activate the alpha 3 subunit promoter, probably as a consequence of protein-protein interactions at the level of the basal transcriptional machinery. Furthermore, an enhancer located in the 3'-untranslated exon of the beta 4 subunit (15, 16), at the beta 4/alpha 3 intergenic region, activates transcription from the alpha 3 and beta 4 subunit promoters in a cell type-specific manner, possibly via a novel ETS domain factor, Pet-1, whose expression is almost restricted to the adrenal medulla (17). Considerable effort has also been dedicated to the transcriptional regulation of the beta 4 subunit. Thus, Gardner and co-workers (18) have shown that Puralpha interacts with a 19-bp element in the beta 4 promoter. In addition, Sp1 (19) and Sp3 (20) transactivate the beta 4 promoter in a synergistic way, an effect possibly mediated by heterogeneous nuclear ribonucleoprotein K, which affects the transactivation of beta 4 promoter activity by Sp1 and Sp3 differentially (21). As no information has been available until now for the promoter of the alpha 5 subunit, we have chosen to focus on it, with the aim of finding a possible link in the regulation of the three subunits. This study reports that at least five positive regulatory elements exist in the alpha 5 promoter proximal region. These elements, all of them GC boxes, were shown to interact with Sp1. Since the alpha 3 promoter is also the target of Sp1 (22), we suggest the possible involvement of this transcription factor in a regulatory mechanism common to the alpha 3, beta 4, and alpha 5 subunits.

    EXPERIMENTAL PROCEDURES

Isolation and Analysis of the 5'-Flanking Sequence of the alpha 5 Subunit-- A cDNA probe containing 152 bp of the 5'-end of exon 2 was used to screen a bovine genomic library in EMBL-3 SP6/T7 (, Heidelberg, Germany) as described previously (8). Several overlapping bacteriophage clones were purified and characterized.

RNase Protection-- Poly(A)+ RNA was directly selected from a lysate of bovine adrenal medulla by oligo(dT)-Dynabeads (Dynal, Oslo, Norway) and used in the RNase protection experiments. Probes were generated with SP6 and T7 polymerases (Boehringer Mannheim, Barcelona, Spain), [alpha -32P]CTP (Amersham Pharmacia Biotech, Madrid, Spain), and the corresponding linearized templates (in the pSPT18 vector, Boehringer Mannheim). A 431-bp BglII-PvuII fragment of the alpha 5 gene that included 163 bp 5' to exon 1 and 249 bp downstream in the same exon was subcloned into the BamHI and HincII sites of pSPT18. After linearization of the plasmid with EcoRI, a probe of 479 nucleotides was synthesized with SP6 polymerase. As control, a cRNA sense fragment of 368 nucleotides was synthesized by linearizing the same template with HincII and using T7 polymerase. This cRNA protected a fragment of 358 nucleotides upon RNase treatment. Parallel experiments were carried out with a smaller probe that overlapped the first one. For this purpose, a 341-bp fragment of the alpha 5 gene that included 319 bp of the 5'-end of the first probe (downstream of the HincII site mentioned above) was also subcloned into pSPT18. After linearization of the plasmid with EcoRI, a probe of 403 nucleotides was synthesized with SP6 polymerase. The same control sense cRNA used above then produced a protected fragment of 328 nucleotides when used instead of adrenal medulla RNA (see Fig. 2 for further explanations). RNase protection experiments were performed using an RNase protection kit (Boehringer Mannheim) as indicated by the manufacturer. Protected fragments were separated on a 7 M urea and 6% acrylamide gel along with several other labeled RNAs of known size, which were also synthesized and used for calibration.

Plasmid Constructions-- All alpha 5 promoter-luciferase gene fusions were made in the pGL2-Basic vector (Promega, Madison, WI), introducing in its polylinker, upstream of the luciferase gene, the suitable alpha 5 promoter fragments. These fragments were generated with restriction enzymes and directly cloned into pGL2-Basic or subcloned first in pBluescript and then transferred to pGL2-Basic. The vector pGL2-Control, which expresses the luciferase gene under the regulation of the SV40 promoter and enhancer sequences, was used to check luciferase activity. Deletion analysis of the most promoter-proximal region was performed by generating polymerase chain reaction fragments with suitable sense oligonucleotides and an antisense primer (5'-CTTTATGTTTTTGGCGTCTTCC-3') that anneals to the pGL2-Basic vector downstream of the site of transcription initiation.

The basic strategy for site-directed mutagenesis of the different elements in region -111 to -40 of the alpha 5 promoter (see Fig. 6) consisted of the following steps. (a) We performed polymerase chain reaction (25 cycles at 94 °C for 10 s, 62 °C for 30 s, and 68 °C for 45 s) amplification of p111alpha 5LUC (or its single or double mutants when double or quadruple mutants were desired, respectively) with appropriate mutagenic primers in the sense orientation, which generated restriction sites useful for further mutant constructions and to confirm mutagenesis. We used the same oligonucleotide mentioned above as antisense primer. The introduced mutations are indicated in lowercase letters in Fig. 6A (sites 1-4) and Fig. 10A (site 5). The mutant sequences did not create any known binding site for transcription factors as predicted by the MatInspector data base search (23). (b) Polymerase chain reaction products were cloned into pBluescript, sequenced, and transferred to the appropriate construct into the pGL2-Basic vector.

Cell Culture and Reporter Assays-- Chromaffin cells were isolated from bovine adrenal glands as described (24) and cultured in 90% Dulbecco's modified Eagle's medium (Sigma, Madrid), 10% fetal calf serum, 10 µM cytosine arabinoside, and 10 µM 5-fluoro-2'-deoxyuridine (Sigma) to prevent fibroblast proliferation. SHSY-5Y human neuroblastoma cells were grown in 90% Eagle's minimal essential medium with Glutamax-1 (Gibco-BRL, Barcelona) and 10% fetal calf serum. COS cells were grown in 90% Dulbecco's modified Eagle's medium and 10% fetal calf serum.

Plasmids were banded in two gradients of CsCl. Both cell types were transfected by the calcium phosphate procedure (25). Chromaffin cells on 48-well plates (5 × 105 cells/well) were incubated with 0.75 µg of pGL2 vector or an equivalent amount (in molar terms) of the different constructs derived from this vector and with 0.75 µg of beta -galactosidase expression vector pCH110 (Amersham Pharmacia Biotech, Barcelona) as a control of transfection efficiency. SHSY-5Y cells (105 cells/well) or COS cells (5 × 104 cells/well) on 24-well plates were incubated with 1.5 µg of the different alpha 7 constructs and 1.5 µg of pCH110 per well. Cells were harvested after 48 h and lysed with reporter lysis buffer (Promega). beta -Galactosidase and luciferase were then determined in the lysates with the corresponding assay systems (Promega). Luciferase activity was normalized to values obtained with the p163alpha 5LUC (see Fig. 3) or p111alpha 5LUC (see Fig. 6) plasmid in the same cell type. When comparing alpha 5, alpha 7, and beta 4 promoters (see Fig. 4), representative constructs for each of the subunits, giving the maximal promoter activity, were chosen. They are indicated in the corresponding figure legends.

Electrophoretic Mobility Shift Assay-- Crude nuclear extracts were prepared from chromaffin and SHSY-5Y cells as described by Schreiber et al. (26). The DNA fragment corresponding to region -111 to -27 was obtained by digesting pBluescript subclones with EcoRI-KpnI and end-labeled by Klenow filling with [alpha -32P]dATP. The DNA-protein binding reaction volumes were 20 µl containing 10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 10% glycerol, 5 µg of bovine serum albumin, 2 µg of poly(dA-dT)·(dA-dT) (Amersham Pharmacia Biotech), 2 µg of nuclear extract protein, and 20,000 cpm of 32P-labeled probe. Reactions were incubated for 10 min at room temperature; the labeled probe was added; and the incubation was continued for an additional 20-min period. For competition studies, the nuclear extract was incubated with the competing probe prior to the labeled probe during 20 min. Supershift assays were performed by preincubating nuclear extracts with 2 µl of antibodies against different transcription factors (Santa Cruz Biotechnology, Santa Cruz, CA) or rabbit IgG (Sigma) for 3 h on ice before probe addition.

Western Blotting-- Ten µg of nuclear proteins/lane was separated by 10% SDS-polyacrylamide gel electrophoresis. Western blotting was carried out as described by Towbin et al. (27). After the transfer, nitrocellulose membranes were blocked overnight at 4 °C with 5% dry milk in phosphate-buffered saline and incubated in the same way with the anti-Sp1 antibody (1:500) in phosphate-buffered saline and 5% dry milk. After incubation with the secondary antibody at room temperature for 2 h, the bands were visualized by a chromogenic reaction (Sigma Fast, nitro blue tetrazolium, Sigma).

DNase I Footprinting-- The sense strand corresponding to region -111 to -27 of the alpha 5 promoter was end-labeled by Klenow filling with [alpha -32P]dATP. Assays were performed with the Sure Track Footprinting kit (Pharmacia) according to the manufacturer's instructions. Recombinant Sp1 was incubated with the radiolabeled double-stranded fragment (~25,000 cpm) using the binding reaction conditions described above in the EMSA experiments (except for the absence of EDTA and the presence of 2.5 mM MgCl2). Immediately following the 30-min incubation at room temperature, 0.5 mM CaCl2 and 1 mM MgCl2 were added to the reactions. This was followed by the addition of 1 unit of DNase I. The reactions were incubated at room temperature for 1 min and stopped with the addition of stop solution (SDS/EDTA). The DNA was prepared for loading onto a 7 M urea and 8% polyacrylamide sequencing gel (~15,000 cpm/lane), and the Maxam-Gilbert A/G chemical sequencing reaction was included as reference ladder.

    RESULTS

Structure of the 5'-Flanking Region of the alpha 5 Subunit Gene-- To examine the requirements for alpha 5 subunit transcription, its promoter region was isolated and analyzed. A bovine genomic library was screened, and several overlapping clones were isolated. Clone lambda alpha 5-21 contained ~16 kilobases of bovine genomic sequence including exons 1 and 2 and ~1.6 kilobases of 5'-flanking region. This region was further subcloned and sequenced (Fig. 1A). Comparison of this sequence to a data base of binding sequences of known transcription factors revealed the main features of the promoter/regulatory region of the alpha 5 gene: the lack of a TATA box and the presence of several GC boxes, all of them concentrated into ~110 bases located 5' to the transcription initiation site. Two perfect Sp1 consensus sites ((G/T)GGGCGGGGC) were present within this GC-rich region. Additional sites with one mismatch, regarding perfect consensus sequences, were also observed for Egr-1, Ap-1, Oct-1, and Ap-2. It is interesting to note the presence of a contiguous direct repeat of two 52- and 42-bp monomers (Fig. 1B), each of them containing one of the perfect Sp1 sites and two other elements to which this transcription factor could potentially bind.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 1.   The 5'-region of the bovine alpha 5 subunit gene. A, the nucleotide sequence of a fragment of genomic clone lambda alpha 5-21 carrying exon 1 (with the protein sequence indicated underneath in italics), the 5'-end of intron 1 (denoted by an arrowhead), and ~1400 bp of 5'-flanking sequence is indicated. The translation start codon is underlined, and the major transcription initiation site (position +1) is denoted by the arrow. B, shown is the alignment of the 52- and 42-bp direct repeats in the alpha 5 subunit core promoter region. Potential Sp1-binding sites are underlined. The center of each of these sites is separated by ~10-11 bp, or a multiple of this number, indicating that they are approximately located on the same side of the DNA, as each turn of B-DNA contains 10.5 bp (see Ref. 37).

The 5'-end of alpha 5 mRNA was mapped by RNase protection analyses (Fig. 2). A 479-residue antisense riboprobe (Fig. 2, Probe 1) yielded two main protected fragments of ~250 and 249 bases. The major one mapped transcription initiation to an adenosine present in a group of three (position +1, black arrow in Fig. 1) and located ~40 bp downstream of the GC-rich repeats. To improve precision in the determination of the transcription initiation site, a second overlapping probe was used (Fig. 2, Probe 2). In this case, two protected fragments were also observed, which were 157 and 156 bp long and mapped transcription initiation to the same place. Therefore, these were tentatively considered the main transcription initiation sites. Other initiation sites may exist, as this is a typical feature of promoters without TATA boxes, and in fact, minor protected fragments of smaller size and intensity were also observed.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Determination of the alpha 5 subunit gene transcription initiation site(s). The 5'-end of the alpha 5 subunit mRNA was mapped by RNase protection using two alpha 5 probes whose structures are illustrated in the lower part of the figure. T, undigested probes, 479 (Probe 1, lane 1) and 403 (Probe 2, lane 5) bases (b); U, probes digested in the presence of yeast tRNA (lanes 2 and 6); C, probes digested in the presence of a sense cRNA control, yielding protected fragments of 358 (Probe 1, lane 3) and 328 (Probe 2, lane 7) bases; P, protected fragments using 7.5 µg of bovine adrenal medulla poly(A)+ mRNA (lanes 4 and 8). The sizes of several RNA fragments used for calibration of the gel are indicated to the left of each panel, whereas the sizes of the protected fragments are to the right.

Functional Analysis of the alpha 5 Subunit Promoter-- A series of constructs was generated to determine the regions of the alpha 5 subunit promoter that contributed to its maximal activity (Fig. 3). These constructs were introduced into SHSY-5Y and chromaffin cells, a neuroblastoma cell line and a primary cell culture, respectively, that express the alpha 5 subunit endogenously (7, 28). In SHSY-5Y cells, the construct containing 111 bp of alpha 5 promoter sequence plus 155 bp of 5'-noncoding region (p111alpha 5LUC) showed the maximal activity. This construct covered all Sp1 sites already mentioned. A shorter construct (p65alpha 5LUC) with only two Sp1 sites showed a 50% decrease in promoter activity, whereas further 5'-deletions that removed all the Sp1 sites (p39alpha 5LUC, p+7alpha 5LUC, and p+56alpha 5LUC) were inactive. In chromaffin cells, results were similar, suggesting that sequences in the minimal promoter, between 111 and 39 bp upstream of the start site of transcription, appear to be critical for basal transcription of the alpha 5 subunit gene in transient transfection assays. Reporter constructs larger than p111alpha 5LUC did not show significant changes in relative luciferase activity when expressed in chromaffin cells. However, in SHSY-5Y cells, a small but constant decrease was observed from one construct to the next larger one, being maximal with p752alpha 5LUC, which showed a marked decrease in activity (36%). The largest construct tested (p1412alpha 5LUC), however, exhibited increased activity (73%). Therefore, in SHSY-5Y but not chromaffin cells, elements predominantly located between -600 and -750 with respect to the transcription initiation site have a negative effect on alpha 5 promoter activity.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Deletion map analysis of alpha 5 gene promoter activity. SHSY-5Y and chromaffin cells were transfected with each of the plasmids (named palpha 5LUC with the number of promoter base pairs included in the construct) containing the luciferase reporter under the control of the different fragments of the alpha 5 subunit promoter and pCH110/beta -galactosidase as a transfection efficiency control. Promoter activity was normalized to values obtained with the p163alpha 5LUC construct. The means ± S.E. (error bars) are given for two or three individual experiments carried out in triplicate. A scheme of the sequence (nucleotides -1409 to +155) of the bovine alpha 5 subunit gene promoter and of each plasmid used in the deletion studies is shown on the left, including four putative GC-rich regulatory elements.

We next compared the alpha 5 promoter with the SV40 viral promoter, present in the vector pGL2-Control, and the nAChR alpha 7 and beta 4 subunit promoters (Fig. 4). These subunits are also expressed in chromaffin and SHSY-5Y cells (7, 8, 28), probably forming part of the same (beta 4) or different (alpha 7) nAChR subtype in which alpha 5 is present. In addition, the beta 4 subunit gene is located in the same gene cluster as the alpha 5 subunit gene (11, 12), as indicated previously. In chromaffin cells, the maximal nAChR subunit promoter activity corresponded to the alpha 5 subunit, which accounted for about one-half of the activity shown by the SV40 promoter and was 10- and 2-fold higher that the activities of the beta 4 and alpha 7 promoters, respectively. By contrast, in SHSY-5Y cells, the activities of the three subunit promoters were similar and about one-fifth the activity of the SV40 promoter. Therefore, it appears that some cell-specific differences exist among the three nAChR subunit promoters, which in any case are weaker than the SV40 viral promoter.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Comparison of the alpha 5 subunit promoter with the SV40 viral promoter and the nAChR alpha 7 and beta 4 subunit promoters. SHSY-5Y and chromaffin cells were transfected with p111alpha 5LUC, p199alpha 7LUC (see Ref. 50), p(19)beta 4 (a deletion construct giving the maximal activity for the bovine beta 4 promoter (L. M. Valor, A. Campos-Caro, C. Carrasco-Serrano, M. Criado, S. Viniegra, J. J. Ballesta, unpublished results)), and pGL2-Control to compare the activity of the alpha 5, alpha 7, and beta 4 promoters relative to the SV40 viral promoter. Promoter activity was normalized to values obtained with the pGL2-Control plasmid. Data are expressed as described in the legend to Fig. 3.

The alpha 5 promoter constructs already tested in chromaffin and SHSY-5Y cells were also transfected into COS cells in an attempt to find elements that would confer cell specificity. Although this cell line does not express nAChRs, the pattern of promoter activity (Fig. 5) was similar to the one found in chromaffin cells. Thus, p111alpha 5LUC showed the maximal activity. A shorter construct (p65alpha 5LUC) with only two Sp1 sites showed a 44% decrease in promoter activity, whereas further 5'-deletions that removed all the Sp1 sites (p39alpha 5LUC, p+7alpha 5LUC, and p+56alpha 5LUC) were inactive. Constructs larger than p111alpha 5LUC did not show significant changes in luciferase activity relative to this construct. Interestingly, whereas in SHSY-5Y and chromaffin cells, the alpha 5 promoter was clearly weaker than the SV40 promoter, present in the pGL2-Control vector, in COS cells, it was ~2-fold stronger than the viral promoter. Therefore, no cell-specific elements were found in the alpha 5 promoter region analyzed.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 5.   Activity of alpha 5 promoter constructs in COS cells. Each of the alpha 5 promoter-luciferase constructs previously analyzed in SHSY-5Y and chromaffin cells (see Fig. 3) was transfected into COS cells. Promoter activity was normalized to values obtained with the p163alpha 5LUC construct. Data are expressed as described in the legend to Fig. 3.

Initially, four GC boxes present between -111 and -40, two of them representing perfect Sp1 consensus sites and another two with one mismatch, were chosen for mutagenic analysis. Single mutations of the four GC boxes indicated that all of them contribute to the activity of the alpha 5 gene, but in a different way, depending on the type of transfected cell (Fig. 6). Thus, when the most promoter-proximal of the GC boxes was altered (site 1, Fig. 6A), alpha 5 promoter activity in SHSY-5Y cells decreased to ~50% of that observed for the parent construct (p111alpha 5LUC), whereas single mutations of the other three had no effect (Fig. 6B). The double mutant of sites 1 and 2 produced an activity close to the obtained for site 1, whereas the simultaneous mutation of sites 3 and 4 did not have any effect, further suggesting that sites 2-4, alone or in pairs, are not required for optimal promoter activity. Surprisingly, activity was almost abolished when all four GC boxes were altered simultaneously, which may indicate that sites 2-4, together with site 1, do integrate a whole synergistic mechanism required for basal promoter activity. By contrast, in chromaffin cells, mutation of any of the GC boxes produced a similar decrease in promoter activity (50-69%), and double mutants showed a further decline. Finally, as happened with SHSY-5Y cells, the simultaneous mutation of the four GC motifs produced the maximal decrease in activity.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   Sites 1-4 are functional elements required for alpha 5 subunit gene expression. A, the proximal region of the alpha 5 subunit promoter (nucleotides -111 to -40) is depicted with the putative regulatory elements underlined. This region contains putative binding sites for transcription factor Sp1 (boxed). Several nucleotides of each potential element were mutated as indicated below the sequence to yield constructs analyzed in transfection experiments (B). B, the name of each mutant construct indicates the element(s) that have been altered (also crossed out in the scheme). Plasmids were transfected into SHSY-5Y and chromaffin cells, and activities were measured. Luciferase activity was normalized to values obtained with the p111alpha 5LUC construct. Data are expressed as described in the legend to Fig. 3.

Characterization of the Regulatory Elements Present at -111 to -27 of the alpha 5 Promoter by EMSA-- DNA fragments carrying wild-type promoter region -111 to -27 were labeled and incubated with nuclear extracts from chromaffin and SHSY-5Y cells (Fig. 7). Several retarded bands were observed in both cases (Fig. 7 A, lanes 2 and 4). Some of them were common to both extracts (bullet  and open circle ). Recombinant Sp1 produced a main retarded complex (lane 6), coincident in position with one of those observed with nuclear extracts (bullet ). Larger complexes were also observed with recombinant Sp1, probably as the result of the simultaneous binding of two or more Sp1 molecules to the same DNA fragment. Antibody supershift analysis was employed in an attempt to identify the proteins producing the retarded bands. One of the main complexes (bullet ) was retarded by an anti-Sp1 antibody (arrowhead, lanes 3, 5, and 7), whereas no supershift was observed with antibodies against several transcription factors able (Sp3, Egr-1, and Ap-2) or not (Myc, Max, USF1, and USF2) to bind to GC boxes (data not shown). In addition to the main band, several minor ones were also displaced by the anti-Sp1 antibody when using chromaffin cell nuclear extracts (compare lanes 2 and 3). They are probably degradation products of Sp1 protein, which keep the capacity of binding to the DNA probe and being recognized by the antibody. The band labeled with an open circle (open circle ) was more prominent in SHSY-5Y extracts (lanes 4 and 5), but we were not able to identify it. Competition experiments confirmed the specificity and identity of the complex formed by Sp1 (Fig. 7B). Thus, an excess of unlabeled probe neutralized the formation of all complexes (lanes 10 and 13), whereas a synthetic oligonucleotide containing an Sp1 consensus sequence abolished the formation of the Sp1 complex (lanes 11 and 14).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Binding of cell nuclear proteins to the proximal region of the alpha 5 subunit promoter. A, the DNA fragment corresponding to region -111 to -27 was used as a gel mobility shift probe in the presence of 2 µg of crude chromaffin (CR; lanes 2 and 3) or SHSY-5Y (SH; lanes 4 and 5) cell nuclear extracts or recombinant Sp1 (0.2 footprint units, 1 footprint unit/µl) (lanes 6 and 7). Lane 1 is probe run in the absence of protein extracts. Lanes 3, 5, and 7 represent complexes obtained upon adding anti-Sp1 antibodies (Ab). A prominent band (bullet ) was supershifted by Sp1 antibodies (arrowhead). Other complexes were also observed (open circle  and black-square), but were not displaced by any of the antibodies tested (see "Results"). B, the gel mobility assay was run using DNA fragment -111 to -27 as the labeled probe and nuclear extracts from chromaffin (lanes 9-11) and SHSY-5Y (lanes 12-14) cells. Lanes 9 and 12 were without added competitor (Comp.; -). Competitor DNA fragment -111 to -27 (PR; lanes 10 and 13) and an oligonucleotide with a consensus site for Sp1 (Sp1; lanes 11 and 14) were added in 100-fold excess. Lane 8 is probe run in the absence of protein extracts. C, nuclear proteins from chromaffin (lane 15) and SHSY-5Y (lane 16) cells and recombinant Sp1 (lane 17) were separated by SDS-polyacrylamide gel electrophoresis on a 10% resolving gel. Following Western blotting with Sp1 antibodies, two molecular species of ~97 kDa were detected. N.P., nuclear protein.

Western blot analysis of SHSY-5Y and chromaffin nuclear proteins indicated that Sp1 protein was indeed expressed in these cells (Fig. 7C). Two proteins bands (~95-100 kDa) were detected with anti-Sp1 antibodies in chromaffin (lane 15) and SHSY-5Y (lane 16) nuclear extracts, showing the same size as that previously described for Sp1 polypeptides (29). The amount of Sp1 protein detected in both extracts was approximately the same, and both bands had the same intensity. By contrast, recombinant Sp1 (lane 17) showed predominantly one species.

Interactions of Sp1 with the GC Boxes in the alpha 5 Proximal Promoter-- Recombinant Sp1 protein was used in DNase I footprinting (Fig. 8) to document the preferences of this transcription factor for the four GC-rich elements previously characterized in transfection studies (Fig. 6). When using the same probe of the EMSA, Sp1 protected several domains (Fig. 8, lanes 3 and 4): the largest one corresponded to GC boxes 1 and 2 (large filled box on the left), whereas two additional domains were also observed, especially at the highest Sp1 concentration (lane 4). One of them corresponded to GC box 4, and the other overlapped the 3'-half of GC box 3 and a downstream GC-rich element. This element was not as close to the Sp1 consensus binding sequence as the ones previously analyzed and, for this reason, was not included in our previous functional characterization (Fig. 6), but, given the DNase protection results, it was further characterized.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 8.   DNase I analysis of Sp1 interactions within the proximal region of the alpha 5 subunit promoter. The sense strand of the same DNA fragment (-111 to -27) used in EMSA was end-labeled by Klenow filling. The gel-purified fragment was incubated with 0.4 (lane 3) or 1 (lane 4) footprint unit (fpu) of Sp1 and treated with DNase I. A control reaction (Cont.; lane 2) was performed in a similar manner, using bovine serum albumin as the protein component. Following digestion with DNase I, fragments were resolved on an 8% denaturing polyacrylamide gel. A Maxam-Gilbert A/G chemical sequencing reaction was included as a reference ladder (lane 1). To the left is a sequence summary of the protected domains, with numbers corresponding to the putative regulatory elements in Fig. 6.

To confirm that an additional Sp1 site exists in the proximal region of the alpha 5 subunit promoter, EMSA experiments were performed with recombinant Sp1, and the DNA fragment carrying wild-type promoter region -111 to -27 and the corresponding fragment mutated at the four original Sp1 sites were compared (Fig. 9). At low Sp1 concentration, a retarded band was observed with the wild-type probe (lane 3). The same band was observed in the case of the mutant probe, but it was very faint (lane 7). A higher Sp1 concentration increased the intensity of the retarded band with the wild-type probe and even induced the formation of complexes of larger size (lane 4), probably as the result of Sp1 binding to more than one site within a single DNA molecule. In the case of the quadruple mutant, the faint band was more intense (lane 8), but no larger complexes were observed, suggesting that this DNA fragment still has one intact Sp1-binding site. That this Sp1 site is the one immediately downstream of site 3 was demonstrated by mutating it (Fig. 10A) and performing EMSA experiments (Fig. 10, B and C). The combination of the same wild-type probe, already used, with nuclear extracts from chromaffin cells yielded the typical pattern in which a prominent band (Fig. 10B, lane 2, bullet ) was observed. The formation of this band, previously demonstrated to be antigenically related to Sp1 (Fig. 7B), was competed by the unlabeled probe (Fig. 10B, lanes 3 and 4), but not by the same probe mutated at the five Sp1 sites (lanes 5 and 6). Moreover, when the mutant fragment was used as the labeled probe, the prominent Sp1 band was not observed (lane 8). Finally, recombinant Sp1 was unable to produce retarded bands with the quintuple mutant (Fig. 10C, lanes 13 and 14), contrary to what occurred with the quadruple mutant (Fig. 9).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 9.   Binding of recombinant Sp1 to GC motifs within the promoter region of the alpha 5 gene. Labeled wild-type DNA fragment -111 to -27 and the corresponding fragment mutated at the four Sp1 sites previously analyzed (Quadruple Mutant) were used as gel mobility shift probes in the presence of 0.02 (lanes 2 and 6), 0.1 (lanes 3 and 7), and 0.5 (lanes 4 and 8) footprint units of recombinant Sp1. Lanes 1 and 5 contain probe run in the absence of protein (-). bullet , Sp1 bound to a single site; bullet bullet , Sp1 bound to two sites.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 10.   Gel mobility shift assays of the fifth Sp1-binding site. A, region -80 and -71 contains an additional putative binding site for Sp1 (underlined and labeled as 5 in the upper sequence). Several nucleotides of this potential element were mutated, as indicated in the lower sequence, in combination with the previously mutated sites and used as probe (Quintuple Mutant). B, labeled wild-type DNA fragment -111 to -27 and the corresponding quintuple mutant were used as gel mobility shift probes in the presence of 2 µg of crude chromaffin cell nuclear extracts. Competitor (Comp.) DNA fragments corresponding to the wild type (WT; lanes 3 and 4) and the quintuple mutant (QM; lanes 5 and 6) were added in 25- and 100-fold excesses. Lanes 1 and 7 were run in the absence of protein (-). bullet  corresponds to the band that was supershifted by Sp1 antibodies (see Fig. 7), whereas the band indicated by black-square has not been identified. C, the same probes from B were used in the presence of 0.05 (lanes 10 and 13) and 0.2 (lanes 11 and 14) footprint units of recombinant Sp1. Lanes 9 and 12 contained probe run in the absence of protein (-).

The functional significance of the fifth GC box was examined in chromaffin cells by transfecting constructs, made in the context of p111alpha 5LUC (see Fig. 6), in which this element was mutated individually or in combination with the other four. In principle, this element seems to be unable to activate transcription by itself alone since the mutation of the other four, leaving this site intact, decreased activity to very low levels (Fig. 6). Thus, the contribution of this element to transcriptional activation, if any, should be expected in a cooperative manner, as it happens with the other four previously characterized. In fact, the single mutation had an effect on promoter activity similar to the one observed for the other single mutants (50% of the activity of p111alpha 5LUC). The quintuple mutant had 14% of promoter activity (relative to p111alpha 5LUC), close to the value obtained for the quadruple mutant (14.7%). Therefore, it seems that this element mediates the transcriptional activation of the alpha 5 promoter in a collective way, combined with the other GC boxes.

    DISCUSSION

Neuronal nAChRs mediate chemical synaptic transmission, probably regulating transmitter release at many synapses (reviewed in Ref. 5). A relatively large number of genes that encode nAChR subunits have been identified (1), having distinct, although overlapping patterns of expression in the central and peripheral nervous systems. This diversity constitutes, in large part, the molecular basis on which the variety of nAChR properties and neural responses to acetylcholine is established. The nAChR alpha 5 subunit is widely expressed in the peripheral nervous system (7, 30, 31) in combination with alpha 3, beta 4, and, in some cases, beta 2 subunits (9, 32). Moreover, it has been demonstrated recently that the alpha 5 subunit combines with alpha 4, beta 2, alpha 3, and beta 4 subunits (33, 34) in heterologous expression systems, modifying nAChR channel properties. Thus, some information has been obtained regarding alpha 5 subunit function, but nothing was known until now about the cis-elements and trans-acting factors that regulate its expression.

The core promoter region of the alpha 5 subunit does not contain TATA and CAAT boxes, but it does have several GC-rich domains, a feature found in the promoters of the alpha 2 (35), alpha 3 (13), beta 4 (20), and alpha 7 (10, 36) subunits. Moreover, the structure of the alpha 5 subunit promoter appears highly organized with two direct repeats (Fig. 1B), each containing crucial elements for promoter activity. From 5'-end deletion analysis (Fig. 3), we determined that the region located between nucleotides -111 and +155 was necessary for the basal promoter activity detected in SHSY-5Y and chromaffin cells. A large loss in promoter activity was observed when 72 bp were deleted from the 5'-end (compare p39alpha 5LUC with respect to the larger construct p111alpha 7LUC) (Fig. 3). These constructs were also transfected into COS cells (Fig. 5), which do not endogenously produce alpha 5 subunits, and were even more potent in luciferase activity when using a viral promoter as a reference. Therefore, it is possible that promoter elements needed for cell-specific expression are not included within the promoter fragments used in this study. Nevertheless, the action of negative elements seems evident in SHSY-5Y cells, as demonstrated by the slight but gradual decrease in the activity of larger constructs. Elements located between -660 and -752 appear responsible for the largest decline in activity and could be involved in a silencing mechanism. It is evident that this mechanism might not be totally effective in SHSY-5Y cells since the largest construct (p1409alpha 5LUC) regains activity, and in fact, SHSY-5Y cells endogenously express alpha 5 subunits. However, it could be of relevance in tissues where alpha 5 subunit expression is repressed, although, at least in COS cells, such a mechanism does not seem to be operative.

The most remarkable feature in the deleted region, between -111 and -39, was the presence of at least four closely located Sp1 sites (labeled 1-4 in Fig. 6A). Therefore, these elements appeared to be suitable candidates for controlling promoter activity. Consequently, when these elements were simultaneously mutated in the context of p111alpha 7LUC, promoter activity was almost suppressed, thus suggesting that they play a crucial role in the transcriptional regulation of the alpha 5 gene. Moreover, DNase I footprinting with purified Sp1 protein revealed regions of extended protection, which contained the four Sp1-binding sites and also an additional GC-rich element, close to site 3 (Fig. 8). This site, in contrast to the others, which have no or one mismatch with respect to a perfect Sp1 consensus binding sequence, has two mismatches and, for this reason, was not considered in the initial analysis of promoter activity. However, EMSA (Fig. 10) and gene reporter experiments confirmed the footprinting data indicating that Sp1 can also bind to this site with a functional significance. We postulate that Sp1 contacts the DNA through multiple interactions to form a higher order complex over the promoter region. Interestingly, the five sites are approximately located on the same side of the DNA, as each turn of B-DNA contains 10.5 bp (37), and sites 2, 5, 3, and 4 are 11, 31, 42, and 62 bp apart, respectively, from site 1. This special arrangement could generate an activation environment that would produce more effective interactions with the transcription apparatus, giving rise to the formation of a multiprotein complex that would accomplish transcription activation at a higher level (38). The individual contribution of each Sp1 element to the formation of this hypothetical higher order complex appears differently defined, depending on the cell context. Thus, in SHSY-5Y cells, the only critical site is the most promoter-proximal, perhaps because the possibility of physically direct interactions between Sp1 at this site and the basal transcriptional machinery. The importance of the others only emerges if they are simultaneously altered, suggesting that Sp1 acts synergistically as a whole on the complete region. By contrast, in chromaffin cells, transcriptional activity seems to depend on each of these sites, as alteration of any of them produces a decrease in promoter function. If we assume that the formation of a higher level complex requires several Sp1 sites, then the possibility exists that in SHSY-5Y but not chromaffin cells, other elements can substitute for the Sp1 sites that were gradually altered by mutagenesis. This substitution would be not possible, however, when all of the Sp1 sites are modified. This assumption is supported by the fact that the double mutant of sites 3 and 4 shows only an insignificant decrease (11%) with respect to the activity of the parent construct p111alpha 5LUC (Fig. 6B), whereas the deletion construct p65alpha 5LUC, which lacks the region between -111 and -66, including sites 3-5, but also other sequences, shows a marked decrease (48%) in activity. Perhaps some additional element present in the deleted region becomes effective in SHSY-5Y cells when some but not all of the Sp1 sites are altered. Whatever the mechanism, the primary conclusion of this study is that the basal activity of the alpha 5 subunit promoter is defined by an array of Sp1-binding elements to which this transcription factor can bind to activate transcription in a synergistic manner.

In addition to silencing mechanisms, the alpha 5 subunit promoter, which appears strongly dependent on a ubiquitous transcription factor like Sp1, may be regulated in a tissue-specific manner by this factor in several ways. (a) Availability of Sp1, as levels of this protein have been shown to vary among different tissues (39). (b) Competition with other members of the Sp family that could bind to the same elements. For instance, Sp3 acts with Sp1 in a concerted way to transactivate the nAChR beta 4 subunit (21). However, we have not found binding of Sp3 to the alpha 5 promoter in EMSA of chromaffin and SHSY-5Y nuclear extracts. In other cases, Sp3 has been shown to repress the action of Sp1 (40-42). (c) Formation of heteromeric complexes between Sp1 and other proteins. Protein p107, a member of the retinoblastoma family of proteins, binds Sp1 and represses Sp1-dependent transcription (43). Sp1 also interacts with the RelA subunit of transcription factor NF-kappa B (44) and the cellular protein YY1 (45). (d) Action of Sp1 as a physical link between proximal and distal promoter elements via DNA bending (46) or looping (47).

Finally, we would like to emphasize the role that Sp1 could play in a potential common regulatory mechanism of the alpha 3, beta 4, and alpha 5 subunits. As has been already mentioned, these subunits compose the predominant nAChR subtype in the peripheral nervous system (7, 9, 32) and have their genes clustered in the genome (11, 12). Therefore, a concerted regulation of the expression of the three subunits is plausible. Given that Sp1 (and other members of the Sp family) seems to play a crucial role in the regulation of the alpha 3 (22), beta 4 (20, 21), and alpha 5 (this study) subunits, we propose that this transcription factor, either directly or through other proteins that can regulate its activity, may play the coupling role in the coordinated regulation of the three subunits. Other factors, or perhaps a differential regulation of Sp1, specific to a determined neuronal cell subset, would be responsible for the independent regulation of each subunit, which also must take place, given the dissimilar pattern of expression of these subunits in certain places (48, 49).

    ACKNOWLEDGEMENTS

The excellent technical assistance of Eva Martínez and Mar Francés is appreciated.

    FOOTNOTES

* This work was supported in part by DGICYT Grants PB95-0690 and PM95-0110 from the Ministry of Education of Spain, Grant SC1*CT91-0666 from the Commission of the European Economic Community, and Grant GV-D-VS-20-158-96 from the Generalitat Valenciana.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Recipient of a Consejo Superior de Investigaciones Científicas-Bancaja postdoctoral fellowship.

parallel Predoctoral Fellow from the Generalitat Valenciana.

Dagger Dagger To whom correspondence should be addressed. Tel.: 34-965919479; Fax: 34-965919484; E-mail: Manuel.Criado{at}umh.es.

    ABBREVIATIONS

The abbreviations used are: nAChRs, nicotinic acetylcholine receptors; bp, base pair(s); EMSA, electrophoretic mobility shift assay.

    REFERENCES
Top
Abstract
Introduction
References
  1. Sargent, P. B. (1993) Annu. Rev. Neurosci. 16, 403-443[CrossRef][Medline] [Order article via Infotrieve]
  2. Karlin, A., and Akabas, M. H. (1995) Neuron 15, 1231-1244[Medline] [Order article via Infotrieve]
  3. Papke, R. L. (1993) Prog. Neurobiol. (Oxf.) 41, 509-531[CrossRef][Medline] [Order article via Infotrieve]
  4. McGehee, D. S., and Role, L. W. (1995) Annu. Rev. Physiol. 57, 521-546[CrossRef][Medline] [Order article via Infotrieve]
  5. Role, L. W., and Berg, D. K. (1996) Neuron 16, 1077-1085[Medline] [Order article via Infotrieve]
  6. Criado, M., Alamo, L., and Navarro, A. (1992) Neurochem. Res. 17, 281-287[Medline] [Order article via Infotrieve]
  7. Campos-Caro, A., Smillie, F., Domínguez del Toro, E., Rovira, J. C., Vicente-Agulló, F., Chapuli, J., Juíz, J. M., Sala, S., Sala, F., Ballesta, J. J., and Criado, M. (1997) J. Neurochem. 68, 488-497[Medline] [Order article via Infotrieve]
  8. García-Guzmán, M., Sala, F., Sala, S., Campos-Caro, A., Stühmer, W., Gutiérrez, L. M., and Criado, M. (1995) Eur. J. Neurosci. 7, 647-655[Medline] [Order article via Infotrieve]
  9. Conroy, W. G., and Berg, D. K. (1995) J. Biol. Chem. 270, 4424-4431[Abstract/Free Full Text]
  10. Criado, M., Domínguez del Toro, E., Carrasco-Serrano, C., Smillie, F. I., Juíz, J. M., Viniegra, S., and Ballesta, J. J. (1997) J. Neurosci. 17, 6554-6564[Abstract/Free Full Text]
  11. Couturier, S., Erkman, L., Valera, S., Rungger, D., Bertrand, S., Boulter, J., Ballivet, M., and Bertrand, D. (1990) J. Biol. Chem. 265, 17560-17567[Abstract/Free Full Text]
  12. Boulter, J., O'Shea-Greenfield, A., Duvoisin, R. M., Connolly, J. G., Wada, E., Jensen, A., Gardner, P. D., Ballivet, M., Deneris, E. S., McKinnon, D., Heinemann, S., and Patrick, J. (1990) J. Biol. Chem. 265, 4472-4482[Abstract/Free Full Text]
  13. Yang, X., McDonough, J., Fyodorov, D., Morris, M., Wang, F., and Deneris, E. S. (1994) J. Biol. Chem. 269, 10252-10264[Abstract/Free Full Text]
  14. Fyodorov, D., and Deneris, E. (1996) Mol. Cell. Biol. 16, 5004-5014[Abstract]
  15. Yang, X., Yang, F., Fyodorov, D., Wang, F., McDonough, J., Herrup, K., and Deneris, E. (1997) J. Neurobiol. 32, 311-324[CrossRef][Medline] [Order article via Infotrieve]
  16. McDonough, J., and Deneris, E. (1997) J. Neurosci. 17, 2273-2283[Abstract/Free Full Text]
  17. Fyodorov, D., Nelson, T., and Deneris, E. (1998) J. Neurobiol. 34, 151-163[CrossRef][Medline] [Order article via Infotrieve]
  18. Du, Q., Tomkinson, A. E., and Gardner, P. D. (1997) J. Biol. Chem. 272, 14990-14995[Abstract/Free Full Text]
  19. Bigger, C. B., Casanova, E. A., and Gardner, P. D. (1996) J. Biol. Chem. 271, 32842-32848[Abstract/Free Full Text]
  20. Bigger, C. B., Melnikova, I. N., and Gardner, P. D. (1997) J. Biol. Chem. 272, 25976-25982[Abstract/Free Full Text]
  21. Du, Q., Melnikova, I. N., and Gardner, P. D. (1998) J. Biol. Chem. 273, 19877-19883[Abstract/Free Full Text]
  22. Yang, X., Fyodorov, D., and Deneris, E. S. (1995) J. Biol. Chem. 270, 8514-8520[Abstract/Free Full Text]
  23. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995) Nucleic Acids Res. 23, 4878-4884[Abstract]
  24. Gandía, L., Casado, L. F., López, M. G., and García, A. G. (1991) Br. J. Pharmacol. 103, 1073-1078[Abstract]
  25. Graham, F. L., and van der Eb, A. J. (1973) Virology 52, 456-467[Medline] [Order article via Infotrieve]
  26. Schreiber, E., Matthias, P., Müller, M. M., and Schaffner, W. (1989) Nucleic Acids Res. 17, 6419[Medline] [Order article via Infotrieve]
  27. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract]
  28. Lukas, R., Norman, S., and Lucero, L. (1993) Mol. Cell. Neurosci. 4, 1-12[CrossRef]
  29. Liang, Y., Robinson, D. F., Dennig, J., Suske, G., and Fahl, W. E. (1996) J. Biol. Chem. 271, 11792-11797[Abstract/Free Full Text]
  30. Corriveau, R. A., and Berg, D. K. (1993) J. Neurosci. 13, 2662-2671[Abstract]
  31. Howard, M. J., Gershon, M. D., and Margiotta, J. F. (1995) Dev. Biol. 170, 479-495[CrossRef][Medline] [Order article via Infotrieve]
  32. Conroy, W. G., Vernallis, A. B., and Berg, D. K. (1992) Neuron 9, 679-691[Medline] [Order article via Infotrieve]
  33. Ramírez-Latorre, J., Yu, C. R., Qu, X., Perin, F., Karlin, A., and Role, L. (1996) Nature 380, 347-351[CrossRef][Medline] [Order article via Infotrieve]
  34. Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X., Keyser, K., and Lindstrom, J. (1996) J. Biol. Chem. 271, 17656-17665[Abstract/Free Full Text]
  35. Bessis, A., Savatier, N., Devillers-Thiéry, A., Bejanin, S., and Changeux, J.-P. (1993) Nucleic Acids Res. 21, 2185-2192[Abstract]
  36. Matter-Sadzinski, L., Hernández, M.-C., Roztocil, T., Ballivet, M., and Matter, J.-M. (1992) EMBO J. 11, 4529-4538[Abstract]
  37. Wang, J. C. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 200-203[Abstract]
  38. Pascal, E., and Tjian, R. (1991) Genes Dev. 5, 1646-1656[Abstract]
  39. Saffer, J. D., Jackson, S. P., and Annarella, M. B. (1991) Mol. Cell. Biol. 11, 2189-2199[Medline] [Order article via Infotrieve]
  40. Birnbaum, M. J., van Wijnen, A. J., Odgren, P. R., Last, T. J., Suske, G., Stein, G. S., and Stein, J. L. (1995) Biochemistry 34, 16503-16508[Medline] [Order article via Infotrieve]
  41. Suzuki, M., Kuroda, C., Oda, E., Tsunoda, S., Nakamura, T., Nakajima, T., and Oda, K. (1995) Mol. Cell. Biol. 15, 5423-5433[Abstract]
  42. De Luca, P., Majello, B., and Lania, L. (1996) J. Biol. Chem. 271, 8533-8536[Abstract/Free Full Text]
  43. Datta, P. K., Raychaudhury, P., and Bagchi, S. (1995) Mol. Cell. Biol. 15, 5444-5452[Abstract]
  44. Sif, S., Capobianco, A. J., and Gilmore, T. D. (1993) Oncogene 7, 2501-2509
  45. Seto, E., Lewis, B., and Shenk, T. (1993) Nature 365, 462-464[CrossRef][Medline] [Order article via Infotrieve]
  46. Ikeda, K., Nagano, K., and Kawakami, K. (1993) Gene (Amst.) 136, 341-343[CrossRef][Medline] [Order article via Infotrieve]
  47. Su, W., Jackson, S., Tjian, R., and Echols, H. (1991) Genes Dev. 5, 820-826[Abstract]
  48. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., and Swanson, L. W. (1988) J. Comp. Neurol. 284, 314-335
  49. Wada, E., McKinnon, D., Heinemann, S., Patrick, J., and Swanson, L. W. (1990) Brain Res. 526, 45-53[CrossRef][Medline] [Order article via Infotrieve]
  50. Carrasco-Serrano, C., Campos-Caro, A., Viniegra, S., Ballesta, J. J., and Criado, M. (1998) J. Biol. Chem. 273, 20021-20028[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.